EPCAM and cancer: To further characterise the expression of markers known to confer stem cell-like and self-renewal properties in organoids, the presence of cancer stem cell markers, Sox9, EpCAM and CD44, in the matched metCRC PDOs were assessed via immunofluorescence40–42.